Elicio Therapeutics Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | -9.8% | -38.8% | -63.1% | +93.7% | +883.1% | -100.0% | – | – | – | |
| – | -13.6% | -88.0% | +198.9% | +60.0% | -32.1% | -14.3% | +10.7% | +0.7% | -4.2% | |
| – | -6.0% | +7.1% | -90.4% | +202.6% | +2,449.7% | -103.9% | – | – | – | |
| – | – | +4,568.7% | +225.5% | +30.5% | +25.0% | -64.9% | +33.0% | +48.4% | -26.0% | |
| – | – | – | – | +7.2% | +151.3% | -25.4% | +111.3% | -4.8% | +13.1% | |
| – | -5.9% | +372.8% | +116.5% | +44.7% | +17.8% | -65.8% | +52.5% | +26.7% | -16.5% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | -2.3% | – | – | – | -90.1% | +310.3% | -70.5% | -57.0% | +149.0% | |
| – | +45.1% | -1,255.9% | – | – | – | – | – | – | – | |
| – | +124.3% | – | – | -89.0% | +9,701.4% | +310.3% | – | – | – | |
| – | +105.7% | -3,267.3% | – | – | – | – | – | – | – | |
| – | -96.8% | -23,029.3% | – | – | – | – | – | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.